Guardant Health (GH) Cash & Current Investments (2017 - 2026)

Guardant Health has disclosed Cash & Current Investments across 10 years of filings, most recently posting $1.1 billion for Q2 2026.

• In Q2 2026, Cash & Current Investments rose 67.45% year-over-year to $1.1 billion; the TTM figure through Jun 2026 stood at $1.1 billion (up 67.45% YoY), while the FY2025 annual figure was $1.2 billion, up 43.05% from the prior year.
• Cash & Current Investments came in at $1.1 billion for Q2 2026 at Guardant Health, down from $1.1 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $1.2 billion in Q2 2023 to a low of $580.0 million in Q3 2025.
• Average Cash & Current Investments over 5 years is $957.5 million, with a median of $960.2 million recorded in 2022.
• Year-over-year, Cash & Current Investments tumbled 52.35% in 2022 and surged 67.45% in 2026.
• Over 5 years, Cash & Current Investments stood at $1.0 billion in 2022, then rose by 15.57% to $1.2 billion in 2023, then retreated by 28.12% to $840.0 million in 2024, then jumped by 43.05% to $1.2 billion in 2025, then fell by 12.33% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $1.1 billion in Q2 2026, $1.1 billion in Q1 2026, and $1.2 billion in Q4 2025.